Pharmacokinetics of Bisoprolol

• In: Posters
• At: Dublin (Ireland) (2013)
• Type: Poster
• By: FUKUMOTO, Kyoko (Niigata University of Pharmacy and Applied Life Sciences, Department of Clinical Pharmacokinetics, Niigata, Japan)
• Co-author(s): Yokota, Yoko (Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan)
  Nakamura, Masahiko (Internal Medicine, Yamanashi Prefectural Central Hospital, Kofu, Japan)
  Pitchaimani, Vigneshwaran (Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan)
  Harima, Meilei (Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan)
  Watanabe, Kenichi (Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan)
  Ueno, Kazuyuki (Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan)
  
• Abstract:

  I. Background
  
  Bisoprolol is a selective beta-blocker has been widely prescribed for the treatment of cardiovascular disease. It is eliminated by renal and non-renal routes. Therefore, clinical conditions as renal or hepatic dysfunction may alter bisoprolol metabolism or excretion. However, the pharmacokinetics of bisoprolol has not been clarified ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login